NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 110 participants.

Also called NCT04471909

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 110 participants (planned count) (from the registry)
Sponsor
Endospan Ltd. (from the registry)
Registry
  • NCT NCT04471909
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, New Zealand (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04471909. Non-randomized; no masking; primary purpose treatment. Start 2020-10-20 (actual); primary completion 2025-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness
Acronym
TRIOMPHE
Condition
Aortic Aneurysm
Condition
Intramural Hematoma
Condition
Penetrating Aortic Ulcer
Intervention (Device)
NEXUS Aortic Stent Graft System
Lead sponsor
Endospan Ltd. (class: industry)

Record details

Record id
cardio:ct-nct04471909
Content hash
a75bbe1231d86eac5c3bd3cce7c6345d569e492a176864d0c2847963cb29091c